CONSENSUS I
Last reviewed 01/2018
CONSENSUS I was a randomised, double-blind, placebo-controlled trial of 253 patients with severe heart failure.
When enalapril was added to the conventional heart failure therapy there was a significant 27% reduction in mortality in patients with severe heart failure.
Reference:
- CONSENSUS-I study group, (1987), N Engl J Med, 316, 1429-35.
ACE inhibitors in heart failure